fashion -WSS

fashion

author：fashion 2025-10-01 18:33:19 - browse：51519

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： AI used to predict Covid

leisure time

WSS

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Lab trade group sues FDA to halt regulation of lab

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Average age of first period drops to 11.9 years, study shows

David Sabatini, ex

'CMA Fest' 2023: How to watch, who is performing and more

Wikipedia

fashion

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

BioMarin wins approval for gene therapy to treat hemophilia A

Stigma and the return of syphilis

Medicare details structure of new drug price negotiation program

Hormonal contraceptives don’t actually treat endometriosis

Apple is now the first public company to be valued at $3 trillion

Caribou posts encouraging results on off

In Memoriam: Notable people who died in 2023

Hormonal contraceptives don’t actually treat endometriosis

hotspot

Hormonal contraceptives don’t actually treat endometriosis

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

US jobless claims fall again as labor market continues to flash strength

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Adam's Biotech Scorecard: Do Sarepta's exon

Health insurers say they are turning to AI to cut costs, improve care

leisure time

leisure time

leisure time

explore